Aridis Pharmaceuticals Stock (OTC: ARDS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 82.876K / 63.635K |
Day Range | - - - |
52 Wk Range | 0.050 - 0.540 |
Market Cap | $2.786M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | OTC |
RSI | 0 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aridis Pharmaceuticals (OTCQB: ARDS) through any online brokerage.
There are no as such competitors for Aridis Pharmaceuticals.
The latest price target for Aridis Pharmaceuticals (OTCQB: ARDS) was reported by HC Wainwright & Co. on Monday, November 6, 2023. The analyst firm set a price target for 2.00 expecting ARDS to rise to within 12 months (a possible 3100.00% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aridis Pharmaceuticals (OTCQB: ARDS) is $0.0625 last updated May 31, 2024 at 2:49 PM EDT.
There are no upcoming dividends for Aridis Pharmaceuticals.
Aridis Pharmaceuticals’s Q1 earnings are confirmed for Friday, June 14, 2024.
There is no upcoming split for Aridis Pharmaceuticals.
Aridis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.